Bringing you the latest Business News updates from the science industry


by Heather Hobbs Lyonbipole Celebrates Inauguration of Biotech Park


Lyonbiopole, the competitiveness cluster for health in the Rhône-Alpes region, celebrated the launch of Accinov, a new start-up park for biotech companies developing breakthrough technologies, products and services. Selected through a call-for-projects process launched jointly by the DGCIS (General Directorate for Competitiveness, Industry and Services) of the Ministry of Economy, Industry and Employment, alongside the Caisse des Dépôts et Consignations development bank, the park was also supported by local government: Greater Lyon and the Rhône-Alpes Regional Council through a State-Region project contract for the period 2007-2013. It provides ready-to-use clean room labs offering bio-safety level (BSL 2 facilities as well as support services for advanced technological activities.


Opened in November Accinov already hosts the core facility for bio-production protein engineering of The BIOASTER Technology research Institute.


After 16 months of construction work, business property developer Nexity has just delivered a 6500 m2 turnkey building of four stories, with 3 bio-production units, 24 BSL-2 clean room labs and offi ces to the owner, SEM Patrimoniale of Greater Lyon.


“We are very proud to have completed this ambitious project for SEM Patrimoniale. It demonstrates the wide range of skills offered by Nexity, from simple offi ce buildings to highly complex sites with labs, clean rooms, bio-production units, cleaning, cooling and storage rooms,” added Alexis Perret, Delegate General Manager, Nexity Immobilier d’Entreprise.


“We are pleased to offer companies a one-of-a-kind platform that complements Lyonbiopole’s other infrastructures, in particular that of the Infectious Diseases Center. Accinov will host fi rms entering the market phase of their development. The aim is to boost the regional ecosystem of such fi rms by giving them a solid basis for development. These industrial-quality turnkey facilities give them a leading edge,” explained Philippe Archinard, President of Lyonbiopole.


28401pr@reply-direct.com


Gérard Collomb, Senator and Mayor of Lyon, President of Greater Lyon and Chairman of SEM Patrimoniale urban development company, Jean-Jack Queyranne, President of the Rhône- Alpes Regional Council, former State Minister, Philippe Archinard, President of Lyonbiopole, Alexis Perret, Delegate General Manager of Nexity Immobilier d’Entreprise business property developer, inaugurated the new building of the Accinov platform in the presence of Jean-François Carenco, Prefect of the Rhône-Alpes Region and Rhône County, and Philippe Chêne, President of Accinov, along with Alain Mérieux, Chairman of Mérieux Institute, and Christopher Viehbacher, CEO of Sanofi.


Priorclave Appoints Dealer to Spearhead Ireland Growth


Gilde Healthcare Invests in Virology Services new laboratory services in the fi eld of virology.


Investment fi rm Gilde Healthcare has acquired a majority share in Viroclinics Biosciences, a virology contract research organisation, from Erasmus University Medical Centre in Rotterdam. The transaction paved the way for an exit of Erasmus MC, the founding institute that was pivotal for the initial successful growth path of the company. Viroclinics intends to continue its long lasting collaboration with the Viroscience unit at the Institute and co-develop


Senior members of Brennan & Co (from left to right) John Wilson – Field Service Manager, Greg Brennan – Managing Director, Michael Ensor – Product Manager


Priorclave has appointed Brennan & Company as its southern Ireland agent with responsibility for sales of its complete range of laboratory autoclaves.


Lee Oakley, Sales Director


of Priorclave is delighted with the new appointment since Brennan & Company are well established in Ireland as a major supplier of highly specialised technological equipment to the Scientifi c, Medical and Industrial markets, and comments “I am convinced this is the right partnership, our steam steriliser range complements their current product range and their knowledge level extremely well.”


Talking about the appointment, Gregory


Brennan, Managing Director of Brennan & Company said “the association with Priorclave could not be a better fi t for our Scientifi c Division, apart from an excellent product range which is manufactured to the highest standards, we have the benefi t of being able to offer our customers’ autoclaves that match their brief exactly since Priorclave can adapt or produce special builds. In addition, our customers can have cost effective systems of the highest quality that are designed for their laboratories and they will not be paying for extra system facilities that are not required.”


28024pr@reply-direct.com


“With Gilde as new shareholder we have secured access to capital for the company’s mid- and long- term strategic goals”, said Bob van Gemen, CEO of Viroclinics. “This will enable us to expand our service offering while building on our current strengths. The new partnership with Gilde has neither implications for the management nor organisational structure of the company.”


SLS Donates to Honduras Charity


region as well as doctors running remote rural clinics in this impoverished part of the Americas. The Trust will eventually ship four 40 foot containers from Tilbury to Cartagena in Columbia and then on to Puerto Cortes in Honduras. The donations, including gloves, disposable cleaning tissue, bottles, syringes, pipettes, pipette tips, and funnels are due to arrive in early May.


Science lesson at Vicente


Nottingham-based Scientifi c Laboratory Supplies (SLS) has donated over £3,000 worth of science equipment to the Children of Honduras Trust as part of the company’s ongoing commitment to supporting charitable causes of interest to staff.


This is the second consignment of equipment provide by SLS since 2011 and will be used by pupils at several secondary colleges in the Valle de Angeles


Jennifer Cox founded the Children of Honduras Trust over 40 years ago, providing emergency relief as well as long term development aid: “The SLS contribution will make a real difference to the science education of secondary pupils, as well as primary healthcare, in the region. The thoughtful offer from the company gives encouragement to teachers who would not otherwise be able to demonstrate scientifi c theory in the class room; and items like disposable gloves provide doctors and nurses with vital protection when treating patients.”


SLS Operations Director Peter Lister said: “We identifi ed an opportunity to put some of our stock


Sartorius Closes TAP Bisystems Acquisition successfully


Sartorius, a leading international laboratory and pharmaceutical equipment provider,


completed its acquisition of UK company TAP Biosystems Group plc towards the end of last year.


The cash offer made through Sartorius’ wholly owned subsidiary Sartorius Stedim Biotech of approximately


Jasper van Gorp, Partner at Gilde Healthcare said: “We were impressed by Viroclinics’ high quality clinical laboratory services for the pharmaceutical industry. We believe there is a growing need for this type of service to aid in the development of drugs and vaccines to combat existing and future viruses.”


28538pr@reply-direct.com


Science equipment delivered to Vicente


items to good use by helping the Children of Honduras Trust. Our staff enjoy hearing how their efforts have an impact on the lives of others, and seeing the pictures from the schools and hospitals of items in use. We admire the Trust’s dedication to this valuable work and have been happy to help.”


28407pr@reply-direct.com


€33 million had been approved by TAP Biosystems’ shareholders on 21st November, 2013.


The acquisition will enable Sartorius to further extend its bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development. Founded in 1987, the company is


headquartered Royston, UK, generated sales revenue of approximately €26 million in 2012/2013 and employs around 160 people worldwide.


28408pr@reply-direct.com


To be included in our next issue, send all your Business and Financial News stories to heather@intlabmate.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96